Food and Drug Administration Revitalization Act
|Long title||An Act to amend the Federal Food, Drug,and Cosmetic Act to revitalize the Food and Drug Administration, and for other purposes.|
|Enacted by||the 101st United States Congress|
|Effective||November 28, 1990|
|Statutes at Large||104 Stat. 4583|
|Acts amended||Federal Food, Drug, and Cosmetic Act|
|Titles amended||21 U.S.C.: Food and Drugs|
|U.S.C. sections amended||21 U.S.C. ch. 9 §§ 301 et seq., 371-379, 394|
The Food and Drug Administration Revitalization Act was introduced by the 101st Congress of the United States. Senator Orrin G. Hatch was the chairperson sponsor of the federal revitalization amendment for the Food and Drug Administration.
The Title 21 amendment was signed into law on November 28, 1990 by the 43rd President of the United States George H. W. Bush.
Provisions of the Act
Administrative and laboratory facility consolidation - General Services Administration provided authority to grant contracts for consolidated Food and Drug Administration facilities. The contracts shall be granted for the design, construction, and operation of consolidated Food and Drug Administration facilities.
Recovery and retention of fees for FOIA requests - charge fees shall be applied to recover reasonable costs incurred in processing Freedom of Information requests for records obtained or created under this Act.
Scientific review groups - technical and scientific review groups shall be established as needed to perform functions of the Food and Drug Administration.
Automation of FDA - agency shall automate appropriate activities of the Food and Drug Administration to ensure timely review of regulatory activities under this Act.